Schusslers Immune Tablet
NDC Package 34666-406-01
Package Information
Schusslers Immune (echinacea, ferrum phosphoricum, kali muriaticum, zincum gluconicum) tablets is adults and children 12 years and older: take tablets every 8 hours. This formulation utilizes a tablet delivery system. Marketed by Nartex Laboratorios Homeopaticos, S.a. De C.v., this product is identified by NDC 34666-406.
Identification & Billing
Clinical Specifications
- Copper Absorption Inhibitor - [EPC] (Established Pharmacologic Class)
- Decreased Copper Ion Absorption - [PE] (Physiologic Effect)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Potassium Compounds - [CS]
- Potassium Salt - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 34666 - Nartex Laboratorios Homeopaticos, S.a. De C.v.
- 34666-406 - Schusslers Immune
- 34666-406-01 - 1 BOTTLE in 1 CARTON / 240 TABLET in 1 BOTTLE
- 34666-406 - Schusslers Immune
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 34666-406-01 identifies a specific commercial package of 1 bottle in 1 carton / 240 tablet in 1 bottle of Schusslers Immune, a human over the counter drug labeled by Nartex Laboratorios Homeopaticos, S.a. De C.v.. This tablet is formulated for oral use and contains echinacea, unspecified; ferrosoferric phosphate; potassium chloride; zinc gluconate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Nartex Laboratorios Homeopaticos, S.a. De C.v. on January 13, 2022. The current certification is valid through December 31, 2026.
How is this Nartex Laboratorios Homeopaticos, S.a. De C.v. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 34666040601. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.